StockData
Labcorp Holdings Inc. logo

Labcorp Holdings Inc. (LH) shareholders

LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$368.24−4.22 (-1.13%)

Close on Nov 17, 2026Market cap $29.90BP/E 30.2Yield 0.78%

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
97.9%
79M of 81M shares
Institutional holders
1,043
107 new, 72 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 22 sales
Net sold $11.65M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.6,331,0177.60%13G (passive) amendmentMar 31, 2025
Vanguard Capital Management6,201,5127.52%13G (passive)Mar 31, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of LHValueChange% of portfolio
BlackRock, Inc.6,574,2618.10%$1.84B+129,4050.03%
Vanguard Capital Management LLC5,362,2546.60%$1.50B−13,8660.03%
Victory Capital Management Inc4,837,5735.96%$1.35B+210,4470.76%
State Street Corp3,907,6564.81%$1.09B+44,4850.03%
Vanguard Portfolio Management LLC3,678,7984.53%$1.03B−1,8630.05%
Boston Partners3,051,6903.76%$854.20M+682,8940.76%
Allspring Global Investments Holdings, LLC2,236,9572.75%$635.03M+10,5110.97%
Geode Capital Management, LLC2,188,8902.70%$610.44M+2,9480.03%
Select Equity Group, L.P.1,981,9482.44%$554.95M−192,8372.74%
FMR LLC1,904,8702.35%$533.36M+616,4590.02%
Morgan Stanley1,609,4471.98%$450.65M+111,4200.02%
Dimensional Fund Advisors LP1,367,1661.68%$382.80M+34,3910.07%
JPMorgan Chase & Co1,268,3841.56%$354.62M−264,3390.02%
Invesco Ltd.1,237,6761.52%$346.55M−78,5210.03%
Nordea Investment Management Ab915,9391.13%$254.72M−129,2030.21%
UBS Asset Management Americas Inc887,4311.09%$248.48M−12,7710.05%
Northern Trust Corp883,0761.09%$247.26M−114,3340.03%
Wellington Management Group Llp855,5961.05%$239.57M−103,5430.04%
American Century Companies Inc845,0231.04%$236.61M+34,2180.10%
Bank Of America Corp /De/812,2701.00%$227.44M+87,4590.01%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20261,04379M97.9%107 / 358390 / 726M4M
Q1 20261,02278M96.3%107 / 332378 / 9014M7M
Q4 20251,01680M99.0%140 / 307387 / 10510M8M
Q3 202599679M96.7%107 / 314378 / 595M7M
Q2 202596281M99.9%104 / 339360 / 919M5M
Q1 202596378M96.3%115 / 330351 / 496M5M
Q4 202491278M96.3%116 / 337333 / 927M7M
Q3 202490678M96.6%159 / 299302 / 5814M6M
Q2 202481179M97.6%809 / 00 / 079M0M
Q1 202430M0.0%2 / 00 / 30M0M
Q4 202340M0.0%1 / 11 / 00M0M
Q3 202330M0.0%0 / 30 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

711 funds held LH in Q2 2026, 43% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of LHValue% of fundAs of
Vanguard Total Stock Market Index Fund2,603,8103.21%$729.07M0.03%Jun 30, 2026
Vanguard 500 Index Fund2,124,6152.62%$594.89M0.04%Jun 30, 2026
Vanguard Mid-Cap Index Fund1,776,8382.19%$497.51M0.22%Jun 30, 2026
Allspring Special Mid Cap Value Fund1,536,1001.89%$430.11M3.19%Jun 30, 2026
Victory Sycamore Established Value Fund1,445,0001.78%$404.60M2.62%Jun 30, 2026
iShares Core S&P 500 ETF1,128,3861.39%$315.95M0.04%Jun 30, 2026
Fidelity 500 Index Fund1,060,8761.31%$275.89M0.03%May 31, 2026
Victory Pioneer Fund1,051,9481.30%$294.55M2.63%Jun 30, 2026
Vanguard Value Index Fund779,8260.96%$218.35M0.09%Jun 30, 2026
Invesco S&P 500 Equal Weight ETF694,3360.86%$214.69M0.22%Jul 31, 2026
Fidelity Low-Priced Stock Fund684,3950.84%$211.61M0.85%Jul 31, 2026
Vanguard Windsor Ii Fund622,3000.77%$192.42M0.29%Jul 31, 2026
The Hartford Dividend And Growth Fund610,7180.75%$188.83M1.00%Jul 31, 2026
Disciplined Value Mid Cap Fund598,1510.74%$167.48M0.72%Jun 30, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF579,3640.71%$162.22M0.40%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Adam H. SchechterPresident & CEO, Director102,5650.13%Aug 12, 2026
Brian J. CaveneyEVP, Pres of BLS, CMO & CSO34,5620.04%Nov 12, 2026
Bryan T. VaughnEVP and President, Diagnostics6,8450.01%Nov 5, 2026
Akinbolade OyegunwaEVP, CIO & CTO5,3160.01%Nov 3, 2026
Jonathan C. MeltzerEVP, COO3,6200.00%Sep 3, 2026
Amy B. SummyEVP, Chief Marketing Officer6,9560.01%Aug 6, 2026
Peter J. WilkinsonSVP, Chief Accounting Officer1,7700.00%Aug 5, 2026
Kathryn W. KyleEVP, Chief Legal Officer3,9040.00%Jul 6, 2026
Megan D. BaileyEVP, Pres, Central Labs & Intl5,3320.01%Mar 30, 2026
Anita Z. GrahamEVP, CHRO5,1850.01%Mar 30, 2026
Mark S. SchroederEVP, Pres Diagnostics & COO15,7770.02%Mar 30, 2026
der Vaart Sandra D. vanEVP, Corporate Affairs6,2390.01%Mar 30, 2026
Julia Aijun WangChief Financial Officer, EVP1,8170.00%Feb 13, 2026
Glenn A. EisenbergExecutive Vice President41,5500.05%Mar 31, 2025
Lance BerberianEVP, Special Advisor, Strategy20,0050.02%Mar 31, 2025
Richelle P. ParhamDirector2,2880.00%Nov 3, 2026
Kerrii B. AndersonDirector6,8510.01%Aug 18, 2026
Kirsten Marie KliphouseDirector3,1600.00%Feb 13, 2026
Peter M. NeupertDirector13,7840.02%Feb 13, 2026
Jeffrey A. DavisDirector5,4600.01%Feb 13, 2026
Garheng KongDirector13,7390.02%Feb 13, 2026
Paul RothmanDirector2,5710.00%Feb 13, 2026
Kathryn E. WengelDirector4,1330.01%Feb 13, 2026
John H. SampsonDirector––Feb 12, 2026
Carulla Victor BultoDirector––Feb 12, 2026
Dwight Gary GillilandDirector6,6560.01%Aug 1, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Brian J. Caveney
EVP, Pres of BLS, CMO & CSO
Nov 10, 2026Sale−2,000$372.04$744.08K34,562
Bryan T. Vaughn
EVP and President, Diagnostics
Nov 3, 2026Sale(10b5-1 plan)−306$353.70$108.23K6,845
Akinbolade Oyegunwa
EVP, CIO & CTO
Nov 2, 2026Tax withholding−118$355.59$41.96K5,316
Bryan T. Vaughn
EVP and President, Diagnostics
Nov 2, 2026Tax withholding−194$355.59$68.98K7,151
Akinbolade Oyegunwa
EVP, CIO & CTO
Nov 1, 2026Option exercise+370––5,434
Bryan T. Vaughn
EVP and President, Diagnostics
Nov 1, 2026Option exercise+500––7,345
Richelle P. Parham
Director
Oct 30, 2026Sale−1,078$361.22$389.40K2,288
Kerrii B. Anderson
Director
Aug 17, 2026Sale(10b5-1 plan)−3,000$318.02$954.06K6,563
Adam H. Schechter
President & CEO, Director
Aug 11, 2026Sale(10b5-1 plan)−4,669$320.37$1.50M102,565
Amy B. Summy
EVP, Chief Marketing Officer
Aug 4, 2026Sale−924$306.74$283.43K6,956
Peter J. Wilkinson
SVP, Chief Accounting Officer
Aug 3, 2026Sale−82$309.22$25.36K1,770
Peter J. Wilkinson
SVP, Chief Accounting Officer
Aug 3, 2026Option exercise+1,338$209.25$279.98K3,108
Peter J. Wilkinson
SVP, Chief Accounting Officer
Aug 3, 2026Sale−1,338$309.23$413.75K1,770
Kathryn W. Kyle
EVP, Chief Legal Officer
Jul 2, 2026Sale(10b5-1 plan)−92$286.19$26.33K3,904
Bryan T. Vaughn
EVP and President, Diagnostics
Jul 2, 2026Sale(10b5-1 plan)−234$286.19$66.97K6,746
Kathryn W. Kyle
EVP, Chief Legal Officer
Jul 1, 2026Tax withholding−73$283.88$20.72K3,996
Kathryn W. Kyle
EVP, Chief Legal Officer
Jul 1, 2026Option exercise+256––4,069
Bryan T. Vaughn
EVP and President, Diagnostics
Jul 1, 2026Option exercise+327––7,073
Bryan T. Vaughn
EVP and President, Diagnostics
Jul 1, 2026Tax withholding−93$283.88$26.40K6,980
Kathryn W. Kyle
EVP, Chief Legal Officer
Jun 8, 2026Sale(10b5-1 plan)−762$263.89$201.08K3,813
Adam H. Schechter
President & CEO, Director
May 11, 2026Sale(10b5-1 plan)−5,903$254.50$1.50M107,234
Jonathan C. Meltzer
EVP, Operations
Mar 27, 2026Sale(10b5-1 plan)−839$267.05$224.05K3,620
Peter J. Wilkinson
SVP, Chief Accounting Officer
Mar 27, 2026Sale(10b5-1 plan)−1,633$267.05$436.09K1,852
Adam H. Schechter
President & CEO, Director
Mar 26, 2026Award+58,470––139,243
Adam H. Schechter
President & CEO, Director
Mar 26, 2026Tax withholding−26,106$268.38$7.01M113,137
Jonathan C. Meltzer
EVP, Operations
Mar 26, 2026Tax withholding−711$268.38$190.82K4,459
Jonathan C. Meltzer
EVP, Operations
Mar 26, 2026Award+2,388––5,170
Peter J. Wilkinson
SVP, Chief Accounting Officer
Mar 26, 2026Award+2,388––4,240
Peter J. Wilkinson
SVP, Chief Accounting Officer
Mar 26, 2026Tax withholding−755$268.38$202.63K3,485
Akinbolade Oyegunwa
EVP, CIO & CTO
Mar 26, 2026Tax withholding−382$268.38$102.52K5,064
Akinbolade Oyegunwa
EVP, CIO & CTO
Mar 26, 2026Award+1,340––5,446
Kathryn W. Kyle
EVP, Chief Legal Officer
Mar 26, 2026Tax withholding−451$268.38$121.04K4,575
Kathryn W. Kyle
EVP, Chief Legal Officer
Mar 26, 2026Award+1,584––5,026
Brian J. Caveney
EVP, Pres of ED, CMO & CSO
Mar 26, 2026Tax withholding−863$268.38$231.61K36,492
Brian J. Caveney
EVP, Pres of ED, CMO & CSO
Mar 26, 2026Award+1,986––37,355
Brian J. Caveney
EVP, Pres of ED, CMO & CSO
Mar 26, 2026Tax withholding−4,042$268.38$1.08M35,369
Brian J. Caveney
EVP, Pres of ED, CMO & CSO
Mar 26, 2026Award+9,304––39,411
Anita Z. Graham
EVP, CHRO
Mar 26, 2026Tax withholding−2,879$268.38$772.67K5,185
Anita Z. Graham
EVP, CHRO
Mar 26, 2026Award+6,604––8,064
Megan D. Bailey
EVP, Pres, Central Labs & Intl
Mar 26, 2026Award+1,184––5,332
Megan D. Bailey
EVP, Pres, Central Labs & Intl
Mar 26, 2026Tax withholding−481$268.38$129.09K4,851
Amy B. Summy
EVP, Chief Marketing Officer
Mar 26, 2026Tax withholding−1,836$268.38$492.75K7,880
Amy B. Summy
EVP, Chief Marketing Officer
Mar 26, 2026Award+3,994––9,716
Mark S. Schroeder
EVP, Pres Diagnostics & COO
Mar 26, 2026Award+9,304––15,777
Mark S. Schroeder
EVP, Pres Diagnostics & COO
Mar 26, 2026Tax withholding−4,600$268.38$1.23M11,177
Mark S. Schroeder
EVP, Pres Diagnostics & COO
Mar 26, 2026Award+2,968––14,145
Mark S. Schroeder
EVP, Pres Diagnostics & COO
Mar 26, 2026Tax withholding−1,468$268.38$393.98K12,677
der Vaart Sandra D. van
EVP, Corporate Affairs
Mar 26, 2026Tax withholding−2,722$268.38$730.53K6,239
der Vaart Sandra D. van
EVP, Corporate Affairs
Mar 26, 2026Award+6,382––8,961
Bryan T. Vaughn
EVP, Diagnostics
Mar 26, 2026Tax withholding−451$268.38$121.04K6,746
Bryan T. Vaughn
EVP, Diagnostics
Mar 26, 2026Award+1,584––7,197
Adam H. Schechter
President & CEO, Director
Mar 3, 2026Sale−8,705$279.96$2.44M80,773
der Vaart Sandra D. van
EVP, Corporate Affairs
Feb 27, 2026Sale−547.54$284.91$156.00K2,579
Brian J. Caveney
EVP, Pres of ED, CMO & CSO
Feb 24, 2026Sale−1,500$286.31$429.47K30,107
Peter J. Wilkinson
SVP, Chief Accounting Officer
Feb 19, 2026Sale(10b5-1 plan)−666$277.94$185.11K1,852
Jonathan C. Meltzer
EVP, Operations
Feb 12, 2026Sale(10b5-1 plan)−87$290.42$25.27K2,782
Garheng Kong
Director
Feb 11, 2026Option exercise+897––13,739
Brian J. Caveney
EVP, Pres of ED, CMO & CSO
Feb 11, 2026Tax withholding−211$289.89$61.17K31,607
Brian J. Caveney
EVP, Pres of ED, CMO & CSO
Feb 11, 2026Option exercise+740––31,818
der Vaart Sandra D. van
EVP, Corporate Affairs
Feb 11, 2026Option exercise+376––3,225

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
3.15%
3M shares short
Days to cover
3.0
At 1M shares a day
Change since last report
-0.5%
From 3M shares
Short volume, 20 days
49.9%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Labcorp's stock actually held short. Settlement fails (shares not delivered on time) peaked at 254 shares on Oct 2, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Brian J. Caveney
Officer
Nov 10, 20262,000$744.08KNov 10, 2026Restricted Stock Vesting
Megan D. Bailey
Former Officer
Nov 4, 20263,035$1.10MNov 4, 2026Stock Option Exercise
Bryan T. Vaughn
Officer
Nov 3, 2026306$108.23KNov 3, 2026Restricted Stock Vesting
Richelle P. Parham
Director
Oct 30, 20261,078$389.40KOct 30, 2026Restricted Stock Vesting
Kerrii B. Anderson
Director
Aug 17, 20263,000$954.39KAug 17, 2026Restricted Stock Awards
Adam H. Schechter
Officer, Director
Aug 11, 20264,669$1.50MAug 11, 2026Restricted Stock Vesting
Amy B. Summy
Officer
Aug 4, 2026924$283.43KAug 4, 2026Restricted Stock Vesting
Kathryn W. Kyle
Officer
Jul 2, 202692$26.33KJul 2, 2026Restricted Stock Vesting
Bryan T. Vaughn
Officer
Jul 2, 2026234$66.97KJul 2, 2026Restricted Stock Vesting
der Vaart Sandra D. van
Former Officer
Jul 1, 20267,138$2.00MJul 1, 2026Stock Option Exercise
Kathryn W. Kyle
Officer
Jun 8, 2026762$201.08KJun 8, 2026Restricted Stock Vesting
Adam H. Schechter
Officer, Director
May 11, 20265,903$1.50MMay 11, 2026Restricted Stock Vesting
der Vaart Sandra D. van
Former Officer
May 6, 20266,238$1.60MMay 6, 2026Restricted Stock Vesting
Jonathan C. Meltzer
Officer
Mar 27, 2026839$224.05KMar 27, 2026Restricted Stock Vesting
Adam H. Schechter
Officer, Director
Mar 3, 20268,705$2.44MMar 3, 2026Restricted Stock Vesting

Congress trades

32 trades in Labcorp reported by 10 members of the House

MemberTypeTradedAmountFiled
April McClain Delaney
MD06 · child
SoldAug 25, 2026$100K–250KSep 9, 2026
April McClain Delaney
MD06 · child
Sold (part)Aug 7, 2026$1K–15KSep 9, 2026
April McClain Delaney
MD06 · child
Sold (part)Aug 6, 2026$1K–15KSep 9, 2026
April McClain Delaney
MD06 · child
Sold (part)Aug 5, 2026$1K–15KSep 9, 2026
Tony Wied
WI08 · joint account
BoughtFeb 19, 2026$50K–100KMar 9, 2026
April McClain Delaney
MD06 · child
BoughtFeb 11, 2026$1K–15KMar 10, 2026
April McClain Delaney
MD06 · child
BoughtFeb 4, 2026$1K–15KMar 10, 2026
April McClain Delaney
MD06 · child
BoughtJan 28, 2026$1K–15KFeb 2, 2026
April McClain Delaney
MD06 · child
BoughtNov 17, 2025$1K–15KDec 8, 2025
April McClain Delaney
MD06 · child
BoughtOct 31, 2025$1K–15KNov 4, 2025
April McClain Delaney
MD06 · child
BoughtOct 29, 2025$1K–15KNov 4, 2025
Rob Bresnahan
PA08
BoughtMay 15, 2025$1K–15KMay 31, 2025
Rob Bresnahan
PA08
SoldApr 8, 2025$1K–15KMay 8, 2025
Gilbert Cisneros
CA31
Sold (part)Mar 31, 2025$1K–15KApr 7, 2025
April McClain Delaney
MD06 · child
BoughtFeb 28, 2025$1K–15KMar 20, 2025
April McClain Delaney
MD06 · child
BoughtFeb 27, 2025$1K–15KMar 20, 2025
Rob Bresnahan
PA08
BoughtFeb 25, 2025$1K–15KMar 27, 2025
April McClain Delaney
MD06 · child
BoughtFeb 17, 2025$1K–15KMar 20, 2025
April McClain Delaney
MD06 · child
BoughtFeb 8, 2025$1K–15KMar 20, 2025
April McClain Delaney
MD06 · child
BoughtFeb 5, 2025$1K–15KMar 20, 2025
Rohit Khanna
CA17 · child
BoughtAug 27, 2024$1K–15KSep 6, 2024
Rohit Khanna
CA17 · child
BoughtJun 14, 2024$1K–15KJul 8, 2024
John James
MI10
SoldMar 6, 2024$1K–15KSep 2, 2024
180 days late
John James
MI10
BoughtNov 10, 2023$1K–15KSep 2, 2024
297 days late
Bradley S. Schneider
IL10 · spouse
BoughtJan 12, 2018$250K–500KFeb 15, 2018
Bradley S. Schneider
IL10 · spouse
SoldNov 21, 2017$100K–250KNov 23, 2017
Bradley S. Schneider
IL10 · spouse
BoughtMar 10, 2017$100K–250KMar 25, 2017
Ed Whitfield
KY01
BoughtAug 4, 2015$1K–15KSep 15, 2015
Thomas MacArthur
NJ03 · joint account
SoldMay 27, 2015$1K–15KJun 7, 2015
Thomas MacArthur
NJ03 · joint account
BoughtMay 14, 2015$1K–15KJun 7, 2015
K. Michael Conaway
TX11
SoldNov 3, 2014$1K–15KAug 1, 2015
271 days late
K. Michael Conaway
TX11
BoughtApr 3, 2014$1K–15KAug 18, 2014
137 days late

See a number that looks wrong?